The efficiency of extracts of plants that have
-
Upload
carlos-santos-perez -
Category
Education
-
view
572 -
download
0
description
Transcript of The efficiency of extracts of plants that have
EFFICIENCY OF PLANTS EXTRACTS
THAT CONTAIN MELATONIN IN
PARKINSON DISEASE RATS
Carlos J. Santos Pérez, RISE Student
Background Information
The rats have a very similar neurological system to human.
The cause of Parkinson Disease in a patient is the absence of dopamine.
Symptoms:
Trembling of the extremities
Stiffness
Slowness
Poor balance or coordination
Melatonin
Is an hormone that is produce in the brain by the
pineal gland, from the amino acid tryptophan.
Synthesis and release of melatonin are stimulated
by darkness and suppressed by light, suggesting
the involvement of melatonin in circadian rhythm
and regulation of diverse body functions.
Levels of melatonin in the blood are highest prior
to bedtime.
Melatonin Extract: Achillea millefolium
Achillea millefolium- a plant that is commonly called Achillea, we can found it in North America and it contains a high concentration of melatonin
45.4 ng/g of the plant.
Melatonin & Alzheimer
Recent studies indicate that the presence of
melatonin in Alzheimer improve patient
health, so we can investigate if melatonin
has the same effect in patients with other
neurodegenerative disease , in this case
Parkinson’s Disease.
Objectives
The objectives of this investigation are:
Determine if the extract of Achillea help patience with
Parkinson Disease to control their involuntarily
movements.
Prove that melatonin is a diverse remedial hormone that can
be use to treat Parkinson Disease Symptoms including the
lack of sleeping symptom
Hypothesis
If we apply melatonin extract of Achillea plant in
rats with Parkinson Disease then we should see less
involuntarily movement in the rats at higher
concentrations of extract.
Rotenone
The Rotenone Molecule is a mithocondrial inhibitor that have been used to induce dopaminergic neuronal death.
Inhibit the pathway of dopamine production.
That’s why it cause Parkinson’s Disease.
Rotenone at 3 mg/kg/day will induce degeneration of the nigrostriatal dopaminergicpathway (Caboni, 2004)
This will be subcutaneously
Procedure
Extracts of Achillea millefolium.
Need a Population of mice for the experiment.
Groups:
Control- It consist of 25 healthy rats and 25 sick rats. They
will not be affected by the extracts of Achillea millefolium.
Experimental- It consist of three group:
Concentration of 60%, will be injected subcutaneously.(25 rats)
Concentration of 10% , will be injected subcutaneously(25 rats)
Rats
Control Group
Healthy Rat(No ML)
Rats with Parkinon’s
Disease(No Ml)
Alcohol(25) Levodopa(25)
Experimental Group
Rats with Parkinson’s- 40% concentration of
ML(5mL
subcutaneously)
Rats with Parkinson’s 10% of ML(5mL subcutaneously)
How to do the extracts?
Tincture- Alcoholic extract that alcohol is the solvent.
We will use: 40% and 90% of alcohol and plant.
The ethanol extract have to be placed in rotatory
evaporator to eliminate the solvent, obtaining an
extract, which was weighed and stored in
dissecator.
Variables
Time of Dosis of both of the concentrations: daily
5ml/day This will be for at least 1 year.
Independent Variables- Concentrations and dosis of
the extracts may vary.
Dependent Variable- the temblors and involuntary
movements of the rats.
Type of Data- Qualitative. This research is based
on the observation of the rats behaviors.
Goals
If my hypothesis is reaffirmed I will proceed to use
different plants to do the extracts and compare
results.
As a second phase for my research project I will
expand my research work to primates.
References
Ferri, Fred F. Practical guide to the care of the medical patient. – 7th ed. Pages: 776-777
Marsden CD. Problems with long-term levodopa therapy for Parkinson's disease. Clin Neuropharmacol. 1994;Page 17
Marioni F. A straightforward procedure to biosynthesise melatonin using freshly chopped Achillea millefolium L. as reagent PhytochemistryLetters, Volume 1, Issue 2, 21 August 2008, Pages 107-110
German DC, Manaye K, Smith WK, Woodward DJ, Saper CB. Midbrain dopaminergic cell loss in Parkinson's disease: Computer visualization. Ann Neurol. 1989; 26:507–514.
http://www.ncbi.nlm.nih.gov/pubmed/18289173 Last visit- 7/25/2010
http://www.ncbi.nlm.nih.gov/pubmed/18289173 Last visit- 7/25/2010
http://www.ncbi.nlm.nih.gov/pubmed/15540952 Last visit- 7/25/2010
http://www.ncbi.nlm.nih.gov/pubmed/15540952 Last visit- 7/25/2010